机构:[1]Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China,[2]Department of Rheumatology and Immunology, First Hospital Affiliated to Baotou Medical College, Inner Mongolia Key Laboratory of Autoimmunity, Baotou, China,[3]Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China,[4]Department of Molecular and Translational Science, Faculty of Medicine, Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia,[5]Department of Pathology, The University of Hong Kong, Hong Kong, Hong Kong,[6]Department of Immunology, School of Basic Medical Science, Peking University, Beijing, China,[7]MOE Key Laboratory of Protein Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Institute for Immunology, Tsinghua University, Beijing, China,[8]Department of Orthopedics, Xuanwu Hospital, Capital Medical University, Beijing, China,骨科首都医科大学宣武医院[9]Peking-Tsinghua Center for Life Sciences, Beijing, China,[10]State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China
Natural antibodies, particularly natural IgM, are proved to play indispensable roles in the immune defenses against common infections. More recently, the protective roles of these natural IgM were also recognized in autoimmune diseases. They are mainly produced by B-1 and innate-like B cells (ILBs). Human CD19(+)CD27(+)IgD(+) B cells, also termed as un-switched memory B cells, were proposed to be a kind of ILBs. However, functional features and characteristics of these cells in rheumatoid arthritis (RA) remained poorly understood. In this study, we found that human CD27(+)IgD(+) B cells could produce natural antibody-like IgM. Under RA circumstance, the frequencies of these cells were significantly decreased. Moreover, the IgM-producing capacities of these cells were also dampened. Interestingly, the BCR repertoire of these cells was altered in RA, demonstrating decreased diversity with preferential usage alteration from VH3-23D to VH1-8. Single cell sequencing further revealed the proinflammatory biased features of these cells in RA. These CD27(+)IgD(+) B cells were negatively correlated with RA patient disease activities and clinical manifestations. After effective therapy with disease remission in RA, these cells could be recovered. Taken together, these results have revealed that CD27(+)IgD(+) B cells were impaired in RA with dysfunctional features, which might contribute to the disease perpetuation.
基金:
the National Natural Science Foundation of China (81671604 and 81302554, 91543122, 31530020, and 81501396),
the Beijing Nova Program (Z181100006218044),
the Clinical Medicine Plus X - Young Scholars Project of Peking University (PKU2018LCXQ003),
the Asia Pacific League of Associations for Rheumatology (2013-Q-04).
第一作者机构:[1]Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China,
共同第一作者:
通讯作者:
通讯机构:[1]Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China,[2]Department of Rheumatology and Immunology, First Hospital Affiliated to Baotou Medical College, Inner Mongolia Key Laboratory of Autoimmunity, Baotou, China,[9]Peking-Tsinghua Center for Life Sciences, Beijing, China,[10]State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China
推荐引用方式(GB/T 7714):
Fanlei Hu,Wei Zhang,Lianjie Shi,et al.Impaired CD27(+)IgD(+) B Cells With Altered Gene Signature in Rheumatoid Arthritis[J].FRONTIERS IN IMMUNOLOGY.2018,9(MAR):626.doi:10.3389/fimmu.2018.00626.
APA:
Fanlei Hu,Wei Zhang,Lianjie Shi,Xu Liu,Yuan Jia...&Zhanguo Li.(2018).Impaired CD27(+)IgD(+) B Cells With Altered Gene Signature in Rheumatoid Arthritis.FRONTIERS IN IMMUNOLOGY,9,(MAR)
MLA:
Fanlei Hu,et al."Impaired CD27(+)IgD(+) B Cells With Altered Gene Signature in Rheumatoid Arthritis".FRONTIERS IN IMMUNOLOGY 9..MAR(2018):626